首页> 外文会议>SPIE conference on Optical methods for tumor treatment and detection >Theranostic Nanocells for Simultaneous Imaging and Photodynamictherapy of Pancreatic Cancer
【24h】

Theranostic Nanocells for Simultaneous Imaging and Photodynamictherapy of Pancreatic Cancer

机译:治疗纳米细胞,用于胰腺癌的同时显像和光动力放射治疗

获取原文

摘要

Nanotechnology has the potential to deliver multiple imaging and therapeutic agents to the "right place at the right time". This could dramatically improve treatment responses in cancer which have been so far, dismal as well as allow us to monitor this response online. Pancreatic cancer (PanCa) has a poor prognosis with a 5-year survival rate of only 5% and there is a desperate need for effective treatments. Photodynamic therapy (PDT) has shown promising results in ireating PanCa. Mechanism-based combinations with PDT have enhanced treatment outcome. Agents tested with PDT include Avastin, an antibody against vascular endothelial growth factor (VEGF) which is approved for treating various cancers. Here, we investigate the effect of neutralizing intracellular VEGF using nanotechnology for the delivery of Avastin in combination with PDT. For this we used a construct called "nanocells" in which the photosensitizer was trapped inside polymer nanoparticles and these, with Avastin, were then encapsulated inside liposomes. Simultaneous delivery of drugs in nano-constructs could improve the treatment response of mechanism based combination therapies against cancer. Our studies demonstrate significant enhancement in treatment outcomes when nanocell-based PDT is combined with Avastin in orthotopic PanCa mouse models. We propose a new paradigm for Avastin-based therapy by combining intracellular delivery of the antibody and PDT using nanotechnology for treating PanCa.
机译:纳米技术有可能将多种成像和治疗剂提供给“正确时间”的“正确的位置”。这可能会显着改善癌症中的治疗反应,这是迄今为止,令人沮丧的以及让我们在线监测此响应。胰腺癌(Panca)预后差,5年生存率仅为5%,并且绝望需要有效治疗。光动力疗法(PDT)显示有前途的成果Ireating Panca。基于机制的PDT组合具有增强的治疗结果。用PDT测试的药剂包括Avastin,抗体患有针对血管内皮生长因子(VEGF)的抗体,其被批准用于治疗各种癌症。这里,我们研究中和细胞内VEGF使用纳米技术与PDT组合递送Avastin的效果。为此,我们使用称为“纳米细胞”的构建体,其中光敏剂被捕获在聚合物纳米颗粒内,然后用阿瓦斯汀包封在脂质体内。在纳米构建体中同时递送药物可以改善基于机制的组合治疗癌症的治疗响应。我们的研究表明,当基于纳米镍的PDT与原位Panca小鼠模型中的Avastin结合时,治疗结果的显着增强。通过将抗体和PDT的细胞内递送使用纳米技术来治疗Panca来提出一种基于阿瓦斯汀治疗的新范式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号